Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Strattera (atomoxetine) and Concerta (methylphenidate extended-release) are both medications that treat ADHD (attention deficit-hyperactivity disorder). Concerta is a stimulant medication, but Strattera isn’t. They’re both typically taken once a day. In general, stimulants like Concerta are first-choice options for treating ADHD, while non-stimulants like Strattera are a second-choice option. Stimulants like Concerta start working the day you start taking it. But Strattera takes several weeks to work. Concerta is a controlled substance, but Strattera isn’t. They can both cause nausea, headache, and lowered appetite. Strattera, though, is more likely to cause dry mouth and constipation.
Atomoxetine (Strattera)
Methylphenidate er
Atomoxetine (Strattera)
Methylphenidate er
Summary of Strattera vs. Concerta
Summary for Selective norepinephrine reuptake inhibitor
Prescription only
Atomoxetine, also known by its brand name Strattera, is a non-stimulant medication. It's used to treat attention-deficit hyperactivity disorder (ADHD) in adults and children ages 6 years and up. Atomoxetine (Strattera) comes as capsules that are swallowed whole. You take your dosage either once or twice a day. Side effects are stomach upset and low appetite. It's not a controlled substance like some ADHD medications are. But atomoxetine (Strattera) still has a few serious risks like behavioral changes and heart problems.
Summary for Stimulant
Prescription only
Methylphenidate extended-release (ER) is a first-choice option for people with attention deficit-hyperactivity disorder (ADHD). This once-daily medication can start to work within 2 hours and can last throughout the day. Methylphenidate ER can cause difficulty sleeping and a loss of appetite. It also has a potential risk of misuse and dependency and is thus a controlled substance.